Pharmacokinetic characteristics of long-acting injectable antipsychotics for schizophrenia: an overview

CU Correll, E Kim, JK Sliwa, W Hamm, S Gopal… - CNS drugs, 2021 - Springer
The availability of long-acting injectable (LAI) antipsychotics for the treatment of
schizophrenia provides clinicians with options that deliver continuous drug exposure and …

[HTML][HTML] Lipid based intramuscular long-acting injectables: Current state of the art

J Wilkinson, D Ajulo, V Tamburrini, G Le Gall… - European Journal of …, 2022 - Elsevier
Long acting injectables (LAI) have received increased research and commercial interest due
to their potential for improving treatment effectiveness and adherence for antipsychotic …

Fundamental understanding of drug absorption from a parenteral oil depot

RW Kalicharan, P Schot, H Vromans - European Journal of Pharmaceutical …, 2016 - Elsevier
Oil depots are parenteral drug formulations meant for sustained release of lipophilic
compounds. Until now, a comprehensive understanding of the mechanism of drug …

Alcohol abuse in chronic schizophrenics: implications for management in the community

SD Soni, M Brownlee - Acta Psychiatrica Scandinavica, 1991 - Wiley Online Library
This study was designed to investigate the effects of regular alcohol consumption on chronic
schizophrenic patients maintained on fluphenazine decanoate in the community. A group of …

Spatial distribution of oil depots monitored in human muscle using MRI

RW Kalicharan, P Baron, C Oussoren… - International Journal of …, 2016 - Elsevier
Oil depots are parenteral drug formulations meant for sustained release of lipophilic
compounds. According to mass transport models, the drug-release rate from these injections …

Simultaneous magnetic resonance imaging and pharmacokinetic analysis of intramuscular depots

M Probst, JP Kühn, E Scheuch, A Seidlitz… - Journal of Controlled …, 2016 - Elsevier
The present pilot study introduces a method that might give novel insights in drug absorption
processes from intramuscularly administered depots. An oily suspension or an aqueous …

Where does hydrolysis of nandrolone decanoate occur in the human body after release from an oil depot?

RW Kalicharan, MR Bout, C Oussoren… - International journal of …, 2016 - Elsevier
Long-term therapy of nandrolone (N) is recommended to increase mineral density and
muscle strength. Using a parenteral sustained release drug formulation with nandrolone …

Long-acting injectable antipsychotics and the management of nonadherence

PJ Weiden, H Solari, S Kim, JR Bishop - Psychiatric Annals, 2011 - journals.healio.com
We assume that the reader is familiar with antipsychotic maintenance treatment, as well as
some of the current practice guidelines for LAI use. 1-3 Such practice is often misguided in …

Anatomy and physiology of the injection site: implications for extended release parenteral systems

A McDowell, NJ Medlicott - Long acting injections and implants, 2011 - Springer
Understanding how the biological environment contributes to drug release following
administration is increasingly becoming a focus for drug delivery research. Achieving …

In vitro simulation of distribution processes following intramuscular injection

M Probst, M Schmidt, W Weitschies… - Current Directions in …, 2016 - degruyter.com
There is an urgent need for in vitro dissolution test setups for intramuscularly applied dosage
forms. Especially biorelevant methods are needed to predict the in vivo behavior of newly …